LivingGLP1
Study S000419

Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes

Registration

Registration
NCT01722227
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE3
Masking
TRIPLE
Status
WITHDRAWN
Enrollment
0
Start
2012-11
Primary completion
2017-11
Lead sponsor
University at Buffalo
Conditions
Type 1 Diabetes
Interventions
DRUG:Liraglutide; DRUG:Placebo
Results posted
FALSE
Secondary identifiers
OTHER_GRANT:1-12-CT-20

Registered primary outcomes

  • Mean weekly blood glucose concentrations. [3 Months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.